Skip to main content

Animations

MJFF Publications

2901 - 2910 of 6568 Results
Title
Year
  • Year
  • 2021
  • 2018
  • 2012
  • 2021
  • 2017
  • 2015
  • 2019
  • 2023
  • 2026
  • 2014
  • Summary Details
    OPEN
    Title: Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.1c00290
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Movement disorders in non-encephalopathic Hashimoto's thyroiditis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.020
    Citation Count: 152
  • Summary Details
    OPEN
    Title: Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9
    Journal Name: Gene Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41434-021-00244-y
    Citation Count: 52
  • Summary Details
    OPEN
    Title: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease Models
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068
    Citation Count: 131
  • Summary Details
    OPEN
    Title: CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.12.027
    Citation Count: 110
  • Summary Details
    OPEN
    Title: ToolBox: Live Imaging of intracellular organelle transport in induced pluripotent stem cell‐derived neurons
    Journal Name: Traffic
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/tra.12701
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad072
    Citation Count: 127
  • Summary Details
    OPEN
    Title: Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(26)00029-3
    Citation Count: 7
  • Summary Details
    OPEN
    Title: RETRACTED: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1038/mt.2014.129
    Citation Count: 82
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.